Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CIGNA CORPORATION

(CI)
  Report
Delayed Quote. Delayed Nyse - 11/30 04:10:00 pm
191.9 USD   -3.86%
11/29Cigna Reaffirms Earnings Forecasts for FY21, FY22
MT
11/29CIGNA : Regulation FD Disclosure - Form 8-K
PU
11/29CIGNA CORP : Regulation FD Disclosure (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cigna : AM Best Comments on Credit Ratings of Chubb Ltd and Subsidiaries Following Announced Cigna Acquisitions in Asia-Pacific Markets

10/11/2021 | 04:33am EST

AM Best Comments on Credit Ratings of Chubb Ltd and Subsidiaries Following Announced Cigna Acquisitions in Asia-Pacific Markets.

AM Best has commented that the Credit Ratings (ratings) of Chubb Limited (Chubb) [NYSE: CB] and its insurance subsidiaries remain unchanged following the company's announcement of a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna Corporation (NYSE: CI) in seven Asia-Pacific markets for $5.75 billion dollars in cash. (For a listing of Chubb's ratings, please see the related press release.)

According to Chubb, the operations to be acquired include Cigna's accident and health (A&H) and life insurance business in Korea, Taiwan, New Zealand, Thailand, Hong Kong and Indonesia and its interest in a joint venture in Turkey, all of which generated approximately $3 billion in net premiums written in 2020. The transaction, which is expected to close in 2022, is subject to standard regulatory approvals.

In AM Best's view, the present transaction should significantly strengthen Chubb's already established presence in the Asia-Pacific supplemental A&H and life insurance markets (especially in the Korean A&H sector), a long-term growth area for the company, while complementing its existing product and distribution capabilities. Upon completion of the transaction, Chubb's Asia-Pacific operations and its Global A&H segment will each increase to approximately 20% of the company's global operations (excluding China), enhancing the group's spread of risk and global portfolio balance. These transactions will further strengthen the group's global business profile.

AM Best notes that Chubb's financial leverage to total and to tangible capital may increase modestly as a result of the transaction; however, these measures should remain in the low 20% and 30% ranges, respectively, thereby staying comfortably within tolerances at the current rating levels. This also takes into consideration the group's expanded share repurchase activity, which is expected to continue through midyear 2022. Interest and fixed charge coverage measures are expected to likewise remain especially strong (e.g., comfortably above 8x) given especially strong earnings in 2021 and positive anticipated contributions in 2022 from the acquired operations. Balance sheet strength of the group's principal rating units, reflecting its capital adequacy, as measured by Best's Capital Adequacy Ratio (BCAR), quality of capital and other considerations, is expected to remain at the strongest level prospectively.

This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City.

(C) 2021 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
CHUBB LIMITED -3.01% 179.47 Delayed Quote.20.22%
CIGNA CORPORATION -3.86% 191.9 Delayed Quote.-4.12%
All news about CIGNA CORPORATION
11/29Cigna Reaffirms Earnings Forecasts for FY21, FY22
MT
11/29CIGNA : Regulation FD Disclosure - Form 8-K
PU
11/29CIGNA CORP : Regulation FD Disclosure (form 8-K)
AQ
11/17Seaport Global Starts Cigna at Buy with $270 Price Target On "Stronger" Healthcare Busi..
MT
11/15Africa Ranks Higher in Physical and Social Well-Being Compared to Global Average Despit..
AQ
11/15Africa Ranks Higher in Physical and Social Well-Being Compared to Global Average Despit..
AQ
11/12Morgan Stanley Adjusts Cigna's Price Target to $255 From $275, Reiterates Overweight Ra..
MT
11/12Cigna CEO David Cordani and FedEx CEO Frederick W. Smith Join Together to Highlight the..
AQ
11/08JPMorgan Adjusts Cigna PT to $270 From $285, Maintains Overweight Rating
MT
11/08Credit Suisse Adjusts Cigna's Price Target to $300 from $270, Keeps Outperform Rating
MT
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2021 172 B - -
Net income 2021 5 421 M - -
Net Debt 2021 27 987 M - -
P/E ratio 2021 12,6x
Yield 2021 2,00%
Capitalization 66 156 M 66 156 M -
EV / Sales 2021 0,55x
EV / Sales 2022 0,51x
Nbr of Employees 72 963
Free-Float 82,9%
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 199,61 $
Average target price 260,75 $
Spread / Average Target 30,6%
EPS Revisions
Managers and Directors
David Michael Cordani President, Chief Executive Officer & Director
Brian C. Evanko Chief Financial Officer & Executive Vice President
Isaiah Harris Independent Chairman
Steven B. Miller Chief Clinical Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION-4.12%66 156
UNITEDHEALTH GROUP25.44%425 717
ANTHEM, INC.29.41%101 023
HUMANA INC.4.44%55 022
CENTENE CORPORATION23.11%43 045
MOLINA HEALTHCARE, INC.39.90%17 376